Sleeve gastrectomy with transit bipartition
Sleeve gastrectomy with transit bipartition has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jan 28, 2026: “Efficacy and safety of single-anastomosis gastric bypass variants versus sleeve gastrectomy or Roux-en-Y gastric bypass: a systematic review…”.
1 paper studies it2 findingsUpdated
See all 1 papers on sleeve gastrectomy with transit bipartition
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
What did studies of sleeve gastrectomy with transit bipartition find?
2Studies of sleeve gastrectomy with transit bipartition measured 2 outcomes: gastroesophageal reflux disease and weight loss.
Gastroesophageal reflux disease
downin humans1OR 6.9
1 study
Gastroesophageal reflux disease
downin humans1OR 6.9
Sleeve gastrectomy with transit bipartition decreases gastroesophageal reflux disease in humans (OR = 6.90, CI 1.98–24.09).
Review
Weight loss
upin humans1
1 study
Weight loss
upin humans1
Sleeve gastrectomy with transit bipartition increases weight loss in humans (MD = 3.5%, CI 1.5–5.5%).
Review1 year